Your browser doesn't support javascript.
loading
Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial.
Uhl, Lynne; Kiss, Joseph E; Malynn, Elizabeth; Terrell, Deirdra R; Vesely, Sara K; George, James N.
Affiliation
  • Uhl L; Beth Israel Deaconess Medical Center.
  • Kiss JE; Harvard Medical School, Boston, Massachusetts.
  • Malynn E; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Terrell DR; Beth Israel Deaconess Medical Center.
  • Vesely SK; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • George JN; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Transfusion ; 57(10): 2532-2538, 2017 10.
Article in En | MEDLINE | ID: mdl-28671324

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Randomized Controlled Trials as Topic / Multicenter Studies as Topic / Patient Selection / Rituximab Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Transfusion Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Randomized Controlled Trials as Topic / Multicenter Studies as Topic / Patient Selection / Rituximab Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Transfusion Year: 2017 Document type: Article